Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYHCX vs. XLV: which is better?

Bottom line

RYHCX vs XLV: the short answer

RYHCX (Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

But RYHCX is far broader, holding 135 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 2.4% — a difference of $232 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +4.1% for RYHCX.

Updated Nov 19, 2026

RYHCX vs XLV side by side

RYHCXXLV
TypeMutual fundETF
Fund familyGuggenheimSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio2.4%0.08%
Annual cost per $10k$240$8
10-yr cost on $10k (prospectus)$2,782$103
Max front load0%None
12b-1 fee1%0.02%
1-yr return+12.3%+14.5%
5-yr return (annualized)+4.1%+8.1%
10-yr return (annualized)+6.8%+9.8%
Best quarter+18.4%+14.5%
Worst quarter−14.6%−12.7%
Net assets (fund)$19.4M$40.6B
Number of holdings13565
Portfolio turnover244%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYHCXXLVDifference
2025+13.3%+14.5%−1.2%
2024−0.4%+2.5%−2.9%
2023+4.8%+2.0%+2.8%
2022−12.5%−2.1%−10.4%
2021+18.1%+25.9%−7.8%
2020+17.7%+13.3%+4.5%
2019+21.6%+20.7%+0.9%
2018+0.5%+6.3%−5.8%
2017+22.3%+21.7%+0.6%
2016−10.3%−2.8%−7.5%

Source: Fund prospectus bar charts

Holdings overlap

23 of RYHCX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingRYHCXXLV
Eli Lilly & Company3.63%16.51%
Johnson & Johnson2.88%10.64%
Abbvie Inc2.52%7.74%
Unitedhealth Group Inc2.22%6.57%
Merck & Company Inc2.04%5.52%
Thermo Fisher Scientific Inc1.61%3.24%
Amgen Inc1.56%3.40%
Abbott Laboratories1.42%2.75%
Gilead Sciences Inc1.39%2.73%
Vertex Pharmaceuticals Inc1.34%2.19%
Cvs Health Corp1.31%2.30%
Intuitive Surgical Inc1.31%2.45%
Danaher Corp1.30%2.09%
Pfizer Inc1.25%2.39%
Bristol-myers Squibb Company1.22%2.05%

Source: SEC Form N-PORT

RYHCX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between RYHCX and XLV?
RYHCX (Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. But RYHCX is far broader, holding 135 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, RYHCX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both RYHCX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.